Apyx Medical Corp

APYXNasdaqCIK 719135HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Reports and events: 290 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Apyx Medical Corp, Reports and events
Filed	Form	What it is	Accession number
2020-11-0906:59 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000719135-20-000073
2020-09-1810:57 ET	8-K	1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0000719135-20-000070
2020-08-2110:55 ET	8-K	4.01 Change of auditor; 9.01 Financial statements and exhibits	0000719135-20-000067
2020-08-1011:03 ET	8-K	5.07 Shareholder vote results	0000719135-20-000058
2020-08-1009:01 ET	10-Q	Quarterly reportPeriod 2020-06-30	0000719135-20-000057
2020-08-1007:08 ET	8-K	9.01 Financial statements and exhibits	0000719135-20-000054
2020-06-2613:39 ET	DEF 14A	Proxy statementPeriod 2020-08-06	0000719135-20-000049
2020-05-1108:43 ET	10-Q	Quarterly reportPeriod 2020-03-31	0000719135-20-000043
2020-05-1107:06 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000719135-20-000042
2020-05-0814:12 ET	10-Q/A	Quarterly report, amendedPeriod 2019-03-31	0000719135-20-000036
2020-05-0813:59 ET	10-Q/A	Quarterly report, amendedPeriod 2018-09-30	0000719135-20-000035
2020-03-3115:25 ET	10-K	Annual reportPeriod 2019-12-31	0000719135-20-000029
2020-03-1917:43 ET	8-K/A	2.02 Results of operations; 4.02 Non-reliance on financial statements; 9.01 Financial statements and exhibits	0000719135-20-000026
2020-03-1616:27 ET	8-K	2.02 Results of operations; 4.02 Non-reliance on financial statements; 9.01 Financial statements and exhibits	0000719135-20-000022
2020-01-1311:26 ET	8-K	2.02 Results of operations	0000719135-20-000002
2019-12-0316:42 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0000719135-19-000063
2019-11-1516:05 ET	10-Q	Quarterly reportPeriod 2019-09-30	0000719135-19-000060
2019-11-1217:21 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000719135-19-000053
2019-10-1512:30 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0000719135-19-000048
2019-10-1512:24 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0000719135-19-000047
2019-08-0717:05 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000719135-19-000040
2019-08-0717:04 ET	10-Q	Quarterly reportPeriod 2019-06-30	0000719135-19-000039
2019-08-0712:20 ET	8-K	5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits	0000719135-19-000038
2019-06-2116:25 ET	DEF 14A	Proxy statementPeriod 2019-08-01	0000719135-19-000027
2019-06-0416:10 ET	8-K	4.01 Change of auditor; 9.01 Financial statements and exhibits	0000719135-19-000025
2019-05-0817:21 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000719135-19-000020
2019-05-0817:19 ET	10-Q	Quarterly reportPeriod 2019-03-31	0000719135-19-000019
2019-04-2614:14 ET	8-K	8.01 Other events	0001628280-19-004808
2019-04-0410:32 ET	8-K	2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits	0001628280-19-003915
2019-03-1417:38 ET	10-K	Annual reportPeriod 2018-12-31	0001628280-19-002892
2019-03-1417:34 ET	8-K	2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits	0001628280-19-002891
2019-01-2911:31 ET	8-K	1.01 Entry into a material agreement	0001628280-19-000624
2019-01-0708:45 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000719135-19-000004
2018-12-2807:59 ET	8-K	5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits	0000719135-18-000086
2018-12-1708:21 ET	8-K	5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits	0000719135-18-000084
2018-12-1216:30 ET	8-K	3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits	0000719135-18-000082
2018-11-1309:05 ET	8-K	5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits	0000719135-18-000080
2018-11-0206:20 ET	10-Q	Quarterly reportPeriod 2018-09-30	0000719135-18-000076
2018-11-0116:08 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000719135-18-000073
2018-09-0513:50 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0000719135-18-000059
2018-08-3012:10 ET	8-K	2.01 Completion of an acquisition or disposition; 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits	0000719135-18-000057
2018-08-0116:13 ET	10-Q	Quarterly reportPeriod 2018-06-30	0000719135-18-000055
2018-08-0116:11 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000719135-18-000054
2018-07-2714:56 ET	DEF 14A	Proxy statementPeriod 2018-07-27	0000719135-18-000050
2018-07-0908:00 ET	8-K	1.01 Entry into a material agreement; 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits	0000719135-18-000044
2018-05-1507:02 ET	10-Q	Quarterly reportPeriod 2018-03-31	0000719135-18-000030
2018-05-1416:19 ET	8-K	9.01 Financial statements and exhibits	0000719135-18-000028
2018-05-0316:56 ET	8-K	5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits	0000719135-18-000021
2018-03-1415:06 ET	8-K	5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits	0000719135-18-000017
2018-03-1307:31 ET	10-K	Annual reportPeriod 2017-12-31	0000719135-18-000015

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 5, 2026, 13:09 ET. Listed shows no prices and gives no investment advice.